Moxifloxacin and Ofev drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Moxifloxacin (moxifloxacin) and Ofev (nintedanib esylate). Common drug interactions include dyspnoea among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Moxifloxacin and Ofev. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Moxifloxacin?

Moxifloxacin has active ingredients of moxifloxacin. eHealthMe is studying from 12,980 Moxifloxacin users. Check the latest studies of Moxifloxacin.

What is Ofev?

Ofev has active ingredients of nintedanib esylate. eHealthMe is studying from 24,791 Ofev users. Check the latest studies of Ofev.

On Aug, 01, 2026

11 people who take Moxifloxacin and Ofev together, and have interactions are studied.

Moxifloxacin and Ofev drug interactions.

What are the common drug interactions of Moxifloxacin and Ofev, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Abdominal discomfort
Dizziness
Eye pruritus (eye itching)
Flatulence (flatus expelled through the anus)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hepatic steatosis (fatty liver disease)
Interstitial lung disease
Lower respiratory tract infection
Malaise (a feeling of general discomfort or uneasiness)

male:

Abdominal pain
Abdominal pain upper
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Diarrhoea
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Heart rate increased
Idiopathic pulmonary fibrosis (chronic lung disease)
Oxygen saturation decreased
Pneumonia
Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Moxifloxacin and Ofev, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Abdominal discomfort
Dizziness
Dyspnoea (difficult or laboured respiration)
Eye pruritus (eye itching)
Flatulence (flatus expelled through the anus)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hepatic steatosis (fatty liver disease)
Interstitial lung disease
Lower respiratory tract infection
Malaise (a feeling of general discomfort or uneasiness)

60+:

Diarrhoea
Dyspnoea (difficult or laboured respiration)
Discomfort
Heart rate decreased
Insomnia (sleeplessness)
Lower respiratory tract infection
Lung infection
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pneumonia
Thrombosis (formation of a blood clot inside a blood vessel)

What are the existing conditions these people have? *

Idiopathic Pulmonary Fibrosis (chronic lung disease): 11 people, 100.00%
Pneumonia: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Moxifloxacin and Ofev?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously